Deep-learning algorithms enhance mutation detection in cancer and RNA sequencing

Researchers from the Faculty of Engineering at The University of Hong Kong (HKU) have developed two innovative deep-learning ...
MobiHealthNews

Stanford researchers create algorithm to visually detect skin cancer

Skin cancer is the most common type of cancer, with some 5.4 million cases in the United States each year, and it’s also the most treatable as long as it is detected in the early stages. However, not ...
The Lancet

AI for enhancing efficiency and effectiveness of population breast cancer screening

Breast cancer screening has long been a target use case for artificial intelligence (AI). Developments in computational power ...
News Medical

Case Western cancer researchers develop algorithm to detect DNA copy-number alterations in tumors

Cancer researchers at Case Western Reserve encountered a comparable conundrum when considering reams of data about the body that new technological advances provide — how could they tell what parts of ...
GlobalData on MSN

BMS and Microsoft partner for AI-based lung cancer detection

The partnership aims to deploy AI capabilities that automatically analyse X-ray and CT images to assist radiologists.

Bristol Myers Squibb (BMY), Microsoft (MSFT) Partner to Enhance Early Lung Cancer Detection Through AI

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best inexpensive stocks to buy now. On January 20, Bristol Myers Squibb announced a partnership with Microsoft (NASDAQ:MSFT) to enhance the early ...
Hosted on MSN

AI’s Expanding Role in Medicine: How Artificial Intelligence Is Helping Doctors Detect Cancer Earlier

*Artificial intelligence is rapidly transforming how doctors identify disease, with cancer diagnostics at the forefront of this medical revolution. For millions of patients, AI now provides a crucial ...
ascopubs.org

A fragmentomic tumor score algorithm for enhanced minimal residual disease detection and prognostic prediction in bile duct cancer.

Multimodal thermal therapy to promote the expansion of tumor-reactive–like CX3CR1+GPR56+ T cells in hepatocellular carcinoma patients. Safety and efficacy of HAIC or lenvatinib combined with ...